Experiments in hepatocellular carcinoma tissues from patients have shown that IFI16 induces the formation of inflammasomes in tumor cells, promoting cell death, an effect that can be inhibited by a caspase-1 inhibitor. Here, IFI16 is linked to hepatocellular carcinoma.